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ABSTRACT  
Pharmacoepidemiological studies based on the cohort design are simpler to analyse and their results 
easier to interpret. However, these may not reflect real-life drug use which is a major strength of such 
studies. The nested case-control design is often used instead to avoid the computational burden 
associated with time-dependent explanatory variables. Unlike the classical case-control design which is 
generally easy to programme, that of the nested case-control can pose a number of challenges.  Subjects 
can be chosen as controls more than once and a subject who is chosen as a control can later become a 
case. Indeed controls are chosen from among those in the cohort who are at risk of the event at that time 
(i.e. we sample from the risk set defined by the case). We highlight the main programming challenges of 
the design as well as describe and demonstrate approaches for resolution and appropriate 
implementation. 
 
INTRODUCTION 
The randomized controlled trial (RCT) is universally considered as gold standard in drug research 
primarily because it is capable of providing the most compelling evidence on the efficacy of a healthcare 
intervention1. In a clinical trial, we conceal treatment allocation by a randomization process that we 
maintain through blinding to study participants. However, due to cost implications and other logistical 
considerations, features such as small sample size, short study duration and restricted populations often 
make trials inadequate for determining rates of adverse effects because of low frequencies. Today, many 
consider the post-marketing phase as the richest source of safety data and clinical trials constitute only a 
part of drug safety research. Pharmacoepidemiological studies on drug safety are becoming increasingly 
popular mainly because they reflect real-life utility of drugs, although evidence from these studies is often 
dismissed because of the absence of randomization and the likely consequences of selection bias due to 
confounding. Confounding is the problem that arises when the effect of a factor that is associated with 
both the outcome of interest and exposure is mixed up with the actual exposure effect. 
 
Part of the reason for the increasing growth in these studies is because in some situations, a trial may be 
either inappropriate or inadequate or even impossible to conduct- making pharmacoepidemiological study 
the only alternative to doing nothing. The other is perhaps, because when properly conducted, these 
studies are capable of providing compelling information about the safety of drugs in certain populations 
and settings.  
 
Cohort studies are by far the most common in epidemiological research. Although cohort studies which 
are based on intention-to-treat approach offer a simple design with data which are simpler to analyze and 
results easier to interpret, such studies also intrinsically assume that any time-varying treatment effect 
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that exits can be adequately estimated by a fixed-effect component. However, such an assumption may 
not reflect real-life drug use. Indeed, where sophisticated models such as those involving time-varying 
components are used, these are usually based on assumptions which may be difficult to satisfy and their 
results similarly difficult to interpret. Another drawback of the cohort design for investigating the causes of 
disease with low incidence is that large and lengthy studies may be required to command adequate 
statistical power.   
 
The case-control design is an alternative which avoids this difficulty. In the cohort design, we follow the 
entire cohort and measure the rate of occurrence of new cases in the different exposure groups to 
investigate possible relationship between exposure and disease incidence. The follow–up allows us to 
identify those subjects who develop the disease during the study period as well as those who remain free 
of the disease. By contrast, in a classical case-control design, we identify the subjects who develop the 
disease (the cases) by some mechanism other than that of follow-up and a group of healthy subjects (the 
controls) is used to represent the subjects who do not develop the disease. Here, we try to control for the 
potential effects of confounding factors by matching on such covariates in preference over modeling the 
covariate effects. From programming perspective, the main challenge effectively depends on the size of 
the control population as well as the sampling procedure used to obtain the controls matched to the 
cases.   
 
Studies based on the case-control design can be conducted and completed in a shorter time. Such 
studies generally require smaller sample sizes and hence are usually less expensive. In general, it is the 
only practical approach for identifying risk factors for rare diseases, especially where follow-up of a large 
sample for occurrence of the condition might be impractical. The design is particularly useful for reducing 
the labour and cost of data collection, assessing an exposure not measured in the original cohort and for 
avoiding the computational burden associated with multiple time-dependent explanatory variables. 
 
In the case-control design, the period over which failures are registered as cases is called the study 
period and it is theoretically possible to choose controls to represent the entire source population at the 
start of the study period, including those who go on to become cases. However, this is rarely achievable 
by the classical approach, because the source population is often ill-defined especially in routinely 
collected databases such as those based on healthcare claims. The nested case-control version is used 
to overcome this problem as the controls that are matched to each case are obtained by sampling from 
the very cohort that gave rise to the cases.  In other words, the controls for each case are chosen from 
among those in the cohort who are at risk of the event at that time (i.e. we sample from the risk set 
defined by the case).  Intuitively, comparison of exposure between the case and controls in the risk sets 
does not require all the controls; a representative sample of the controls should be sufficient. Subjects 
can be chosen as controls more than once, and a subject who is chosen as a control can later become a 
case. Indeed, most safety-focused studies are based on this design so as to avoid the computational 
burden associated with time-dependent explanatory variables. The Cox regression is used to estimate the 
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relative change in event rates per unit of increase in exposure, in which the case-control comparison from 
each risk set is quantified in a conditional logistic partial likelihood contribution.  
 
The strength of the nested case-control design rests largely on the appropriateness of the controls 
matched to the cases- which can be quite daunting from programming perspective and the programmer’s 
role is arguably the most vital in such a study. We need to sample the controls from the dynamic risk sets 
whilst ensuring the desired representative quality. We will highlight the main programming challenges of 
the design as well as describe and demonstrate approaches for resolution and appropriate 
implementation. 
  
METHOD 
There are various methods for sampling controls in nested case-control analyses but the method of 
incidence density sampling has been identified as the method of choice for obtaining unbiased results.2 
An efficient incidence density sampling scheme is one in which controls are selected without replacement 
from all persons at risk at the time of case occurrence, excluding the index case itself.3  
To use incidence density sampling to match controls to cases, the programmer must provide a data set 
(i.e. the ‘source’) that describes the study cohort and includes the relevant variables such as those that 
define the case and treatment exposure statuses of patients as well as those for matching.4 Although 
some programs for incidence density sampling have been previously described elsewhere5-7, none of 
them is based on the SAS PROC SQL which offers a robust but simple approach to matching of patients 
on pre-defined variables. 
 
As in the classical case-control study setting, data from a nested case-control study involve series of 
standard 2x2 contingency tables- each table being identified in SAS as a stratum, composing of four cells 
that represent the frequencies of cases and controls classified by exposure status in terms of whether 
each patient in the stratum is exposed or unexposed as shown in Table 1. 
 
Table 1: Illustration of a standard 2X2 Contingency Table 
 Exposed Unexposed 
Case a b 
Control(s) c d 
 
 
In a typical nested case-control study involving incidence density sampling, each case will be matched to 
n controls (n>=1). Thus in the matched dataset, if a=1 (i.e. the case is exposed) then b=0 and vice versa 
for each stratum. Matching is usually on categorical variables such as age, gender, etc. and in general, 
the more variables that are involved in the matching of cases to controls, the smaller the matched study 
sample size.  
 
Programming Approach: 
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Based on a cohort source dataset which we identify as “fullset”, our program uses SAS PROC SQL to 
match each case to all possible controls- see figure 1. For successful implementation, the following four 
variables are vital: pateid (unique patient identifier), tcens (follow-up time), ageindex and gender- the last 
two as matching variables. As first step, a separate file is created out of “fullset” comprising of only the 
patients who experienced the event of interest (“cases” with “pateid” renamed as “pateid_case”) at any 
time during the study period. The INNER JOIN option ensures that any person from “fullset” that could 
match to more than one case from “cases” gets linked to all possible cases for which the person qualifies 
as a potential control and also removes those that are not matched to any case. The “a.tcens <= b.tcens” 
condition ensures that the time at risk is at least as long for the control (b.pateid) as it is for the case 
(a.pateid_case), where as the condition “a.pateid_case ne b.pateid” ensures that a patient does not get 
matched to itself. The variable “rand_num” is used to choose random controls from the possible controls. 
The macro %Macro is used to ensure no more than n controls are matched to each case. Lastly, the 
variable casecon defines the case status of patients in the matched dataset with casecon=1 for a case.  
 
The %Macro is followed by six datasteps- primarily to construct the individual 2x2 matrices (i.e. Table 1) 
which will involve separating the matched cases from their matched controls; assigning censoring status 
flag to each case and control (“casecon”=1 for a case and 0 for a control) and also obtaining relevant 
covariates in the full cohort on each case and control for analysis of the resulting data by conditional 
logistic regression.  
 
In the first step, we create “matched_cases_controls”, each record consisting of a case with a matched 
control as well as relevant covariates of interest and the follow-up time tcens (extracted from “fullset”). In 
the second, we make the case_id (i.e. pateid_case) the identifier (i.e. pateid) and then create in the third 
step, the dataset “id” where we generate an identifier for each stratum (i.e. “matchset”) to link the cases 
with their corresponding matched sets. Next we sort “id” by the control’s id (pateid) to create “id_case”. 
Then in the fourth step, we match the two datasets “matched_cases_controls” and “id_case” by pateid 
(i.e. the control id) and obtain follow-up time and if needed, generate updates of covariates for each 
matched control. This can be a critical step: for time-fixed covariates not involving in the matching (i.e. 
ethnicity, social class), this can be obtained at index date. However, any that are time dependent (for 
example, cumulative exposure level, duration of an important comorbidity), updated values of the 
covariates will need to be obtained on both case and its matched controls at the event time (tcens). In 
other words, such covariates can only be calculated after construction of the risk sets and as at the time 
the case experienced the event. Indeed, the final two steps are used to complete construction of the 
individual risk sets (i.e. 2x2 blocks), thus completing the data preparatory steps for analysis by conditional 
logistic regression.   
 
 
 
Figure 1: Program for Matching Cases to Controls Based on Incidence Density Sampling 
* The Matching procedure- matching each pateid_case to every qualified pateid 
on ageindex and gender *; 
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proc sql; 
create table join1 as select distinct 
   a.pateid_case, a.tcens, a.ageindex, a.gender, 
   b.pateid, ranuni(12345) as rand_num 
   from cases a inner join fullset b 
   on (a.tcens) <=b.tcens       /* control is in risk set at a.tcens */ 
   and a.pateid_case ne b.pateid  /* control is not the case */ 
   and a.ageindex-1 <= b.ageindex <= a.ageindex+1  /* similar age +-1 */ 
   and a.gender = b.gender          /* control is same gender as case */ 
   order by pateid_case, rand_num; 
quit; 
 
* Macro that selects only “n” matched controls for each case *; 
%Macro match(controlsnum); 
data match(keep=pateid_case pateid); 
  set join1; 
  by pateid_case rand_num; 
  retain mcount; 
  mcount+1; 
  if first.pateid_case then mcount=1; 
  if mcount le &controlsnum; 
run; 
 
%mend match; 
quit; 
 
* Input the number of controls (n) to match to each case *; 
%match(n); 
 
 
* Output full dataset of matched cases and controls *; 
data matched_cases_controls_all;   
  set match; 
run; 
 
proc printto; 
run; 
 
 
 
*To separate the matched cases from their matched controls for purpose of 
assigning event flag and also for obtaining the covariates in the database *; 
data matched_cases_controls; 
  merge matched_cases_controls_all(in=a) 
        pnsurv.study_all(in=b keep=pateid tcens 
                                      rename=(pateid=pateid_case)); 
  by pateid_case; 
  if a=1 and b=1; 
run; 
 
proc sort data=matched_cases_controls;  
by pateid_case; 
run; 
 
 
 
* To retain the matching identifier (i.e. assign case identifier to its 
matched controls) for accurate update of the covariates at corresponding 
event time and assignment of censoring status *; 
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data case_id (keep=pateid pateid_case tcens); 
  set matched_cases_controls; 
  by pateid_case; 
  if first.pateid_case; /* only the first observation to identify a case */ 
        pateid=pateid_case; /* make the case_id as the identifier */ 
run; 
 
data id (keep= pateid pateid_case matchset tcens); /*generate id to link 
cases with their matched sets */ 
set case_id; 
by pateid_case; 
matchset=_N_; 
run; 
 
proc sort data=matched_cases_controls; 
by pateid; 
run; 
 
proc sort data=case_id; 
by pateid; 
run; 
 
* To obtain follow-up time and if needed, generate updates of covariates for 
each matched control *; 
data matched_cases_controls1;  
merge matched_cases_controls case_id(keep= pateid pateid_case tcens);  
by pateid pateid_case; 
run; 
 
proc sort data=matched_cases_controls1; 
by pateid_case; 
run; 
 
data final_matched_temp; /* Assign the matchset identifier to all records */ 
merge matched_cases_controls1 id(keep=pateid_case tcens matchset 
rename=(matchset=statu)); 
by pateid_case; 
run; 
 
proc sort data= final_matched_temp; /* reordered by original identifier */  
by pateid; 
run; 
 
data pnsurv.final_matched_all(drop=pateid_case); /* ready for analysis */ 
set final_matched_temp; 
if pateid=pateid_case then casecon=1; 
else casecon=0; 
run; 
 
CONCLUSION  
Observational studies involving the nested case-control design are now commonplace and the trend of 
increased usage of the design in preference over the much simpler cohort design is likely to accelerate 
over time for a number of reasons, already described in epidemiological literature.8-11 The problem of 
time-varying treatment arguably provides the main rationale for the popularity of the nested case-control 
design in safety studies and today, most published pharmacoepidemiological safety studies are based on 
the design despite the known problems of bias associated with the design.11-12 To minimize the potential 
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effects of confounding factors- the main source of bias- we match cases to controls on at least, the most 
important confounding covariates in preference over modeling their effects. This is a process that involves 
sampling of potential controls and although there are many sampling approaches, that of incidence 
density sampling is widely recognized as the best.  From programming perspective, the main challenges 
depend on the size of the control population and appropriate implementation of the recommended 
sampling approach. 
 
In this paper, we have described a simple approach for an accurate implementation of the nested case-
control design based on a SAS program, generic enough for easy adaption to any given study involving 
the design. Our approach may be first to utilize the matching provision offered by SAS PROC SQL to 
achieve exact incidence density sampling from the dynamic risk sets of the nested case-control design, 
whilst also ensuring appropriate implementation of all the vital conditions of the design.    
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